EPOGEN is a Intravenous; Subcutaneous Solution in the Human Prescription Drug category. It is labeled and distributed by Amgen Inc. The primary component is Erythropoietin.
| Product ID | 55513-144_0b8ee1a8-d7d1-46c9-b688-6fbd8dcaccca |
| NDC | 55513-144 |
| Product Type | Human Prescription Drug |
| Proprietary Name | EPOGEN |
| Generic Name | Epoetin Alfa |
| Dosage Form | Solution |
| Route of Administration | INTRAVENOUS; SUBCUTANEOUS |
| Marketing Start Date | 1993-08-16 |
| Marketing Category | BLA / BLA |
| Application Number | BLA103234 |
| Labeler Name | Amgen Inc |
| Substance Name | ERYTHROPOIETIN |
| Active Ingredient Strength | 10000 [iU]/mL |
| Pharm Classes | Erythropoiesis-stimulating Agent [EPC],Erythropoietin [CS],Increased Erythroid Cell Production [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 1993-08-16 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA103234 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1993-08-16 |
| Marketing Category | BLA |
| Application Number | BLA103234 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1993-08-16 |
| Ingredient | Strength |
|---|---|
| ERYTHROPOIETIN | 10000 [iU]/mL |
| SPL SET ID: | 1f2d0b28-9cc5-4523-80b8-637fdaf3f7a5 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 55513-126 | EPOGEN | epoetin alfa |
| 55513-144 | EPOGEN | epoetin alfa |
| 55513-148 | EPOGEN | epoetin alfa |
| 55513-267 | EPOGEN | epoetin alfa |
| 55513-283 | EPOGEN | epoetin alfa |
| 55513-478 | EPOGEN | epoetin alfa |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() EPOGEN 73699422 1543197 Live/Registered |
AMGEN INC. 1987-12-07 |